Emerging therapies for severe asthma

Emerging therapies for severe asthma

Item
http://www.wikidata.org/entity/Q26861260
Neuroimmune semaphorin 4A as a drug and drug target for asthmaInhibiting AKT phosphorylation employing non-cytotoxic anthraquinones ameliorates TH2 mediated allergic airways disease and rhinovirus exacerbation.Omalizumab: clinical use for the management of asthma.Guidance on the diagnosis and management of asthma among adults in resource limited settings.Dual targeting strategies with bispecific antibodies.Efficacy and safety of high-dose ciclesonide for the treatment of severe asthma.Novel glucocorticoid receptor agonists in the treatment of asthma.Lebrikizumab in the personalized management of asthma.You can control your asthma if appropriately managed.Effect of inhaled inactivated Mycobacterium phlei in children with moderate asthma.The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis.
P2860

Emerging therapies for severe asthma

Item
http://www.wikidata.org/entity/Q26861260
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Emerging therapies for severe asthma
@ast
Emerging therapies for severe asthma
@en
Emerging therapies for severe asthma
@nl
type
label
Emerging therapies for severe asthma
@ast
Emerging therapies for severe asthma
@en
Emerging therapies for severe asthma
@nl
prefLabel
Emerging therapies for severe asthma
@ast
Emerging therapies for severe asthma
@en
Emerging therapies for severe asthma
@nl
P1433
P1476
P2093
P275
P2860
P2888
P304
P31
P356
P407
P478
P50
P5008
P577
P5875
P698
P921
P932
P356
P1433
P1476
Emerging therapies for severe asthma
@en
P2093
P275
P2860
P2888
P304
P31
P356
P407
P478
P50
P5008
P577
P5875
P698
P921
P932